|
Monk, J Paul; Halabi, Susan; Picus, Joel et al. (2012) Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782. Cancer 118:4139-47
|
|
Ianelli, C J; DeLellis, R; Thorley-Lawson, D A (1998) CD48 binds to heparan sulfate on the surface of epithelial cells. J Biol Chem 273:23367-75
|
|
Nicholson, L J; Hopwood, P; Johannessen, I et al. (1997) Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells. Oncogene 15:275-83
|
|
Brodeur, S R; Cheng, G; Baltimore, D et al. (1997) Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J Biol Chem 272:19777-84
|
|
Miyashita, E M; Yang, B; Babcock, G J et al. (1997) Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71:4882-91
|
|
Ianelli, C J; Edson, C M; Thorley-Lawson, D A (1997) A ligand for human CD48 on epithelial cells. J Immunol 159:3910-20
|
|
Khan, G; Miyashita, E M; Yang, B et al. (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5:173-9
|
|
Decker, L L; Shankar, P; Khan, G et al. (1996) The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 184:283-8
|
|
Thorley-Lawson, D A; Miyashita, E M; Khan, G (1996) Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol 4:204-8
|
|
Sutkowski, N; Palkama, T; Ciurli, C et al. (1996) An Epstein-Barr virus-associated superantigen. J Exp Med 184:971-80
|
Showing the most recent 10 out of 15 publications
